Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation. (Q53174532)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 May 2010

edit

Language	Label	Description	Also known as
English	Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.	scientific article published on 10 May 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

title

Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

main subject

uterine tube

1 reference

based on heuristic

inferred from title

fallopian tube carcinoma

1 reference

based on heuristic

inferred from title

author

Steven A. Narod

series ordinal

10

object named as

Steven A Narod

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

Beth Karlan

series ordinal

8

object named as

Beth Karlan

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

author name string

Danielle Vicus

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

Amy Finch

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

Barry Rosen

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

Isabel Fan

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

Linda Bradley

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

Ilana Cass

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

Ping Sun

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

John McLaughlin

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

Hereditary Ovarian Cancer Clinical Study Group

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

language of work or name

English

0 references

publication date

10 May 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

published in

Gynecologic Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

volume

118

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

page(s)

155-159

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

cites work

Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

A genetic epidemiological study of carcinoma of the fallopian tube

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Incidence of malignant fallopian tube tumors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Precursors to pelvic serous carcinoma and their clinical implications

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975-2004.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

A prospective study of reproductive factors and risk of epithelial ovarian cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Ovarian cancer and hormone replacement therapy in the Million Women Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Hormone therapy and ovarian cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Estrogen stimulation of ovarian surface epithelial cell proliferation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Possible role of ovarian epithelial inflammation in ovarian cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.03.009

retrieved

7 January 2021

Identifiers

DOI

10.1016/J.YGYNO.2010.03.009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

PubMed publication ID

20452659

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20452659

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/20452659

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53174532&oldid=1750849778"